U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad
The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23
This websiteโs original language is English. For translation, click the globe icon or choose Translate in the menu.
3 matching records found
The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23
Lyfius Pharma Private Limited's facility in Kakinada SEZ is helping India cut its dependence on imported raw materials for essential antibiotics, the Minister says in a social media post